LFMD logo

LifeMD, Inc. Stock Price

NasdaqGM:LFMD Community·US$155.5m Market Cap
  • 4 Narratives written by author
  • 1 Comments on narratives written by author
  • 114 Fair Values set on narratives written by author

LFMD Share Price Performance

US$3.23
-1.76 (-35.27%)
US$9.25
Fair Value
US$3.23
-1.76 (-35.27%)
65.1% undervalued intrinsic discount
US$9.25
Fair Value
Price US$3.23
AnalystConsensusTarget US$9.25
AnalystHighTarget US$18.00
AnalystLowTarget US$8.00

LFMD Community Narratives

AnalystConsensusTarget·
Fair Value US$9.25 65.1% undervalued intrinsic discount

Expanding Care Domains And Telemedicine Will Unlock New Markets

1users have liked this narrative
1users have commented on this narrative
18users have followed this narrative
AnalystHighTarget·
Fair Value US$18 82.1% undervalued intrinsic discount

Telemedicine Adoption And Chronic Care Expansion Will Reshape Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystLowTarget·
Fair Value US$8 59.6% undervalued intrinsic discount

Intensifying Regulation And Churn Will Limit Prospects While Stability Emerges

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
LFMD logo
LifeMD

LifeMD is a diamond in the making

Telehealth is the future of healthcare in america and around the world. Most people don’t want to wait hours in the hospital or even weeks for an appointment.Read more

View narrative
426
users have viewed this narrative
5users have liked this narrative
0users have commented on this narrative
17users have followed this narrative
US$30.3
89.3% undervalued intrinsic discount
MathieuMRoy's Fair Value
Revenue
21% p.a.
Profit Margin
14.71%
Future PE
31.41x
Price in 2030
US$43.86
US$18
82.1% undervalued intrinsic discount
Revenue
17.99% p.a.
Profit Margin
9.76%
Future PE
33.4x
Price in 2028
US$21.14
US$8
59.6% undervalued intrinsic discount
Revenue
13.17% p.a.
Profit Margin
4.07%
Future PE
40.34x
Price in 2028
US$9.4

Trending Discussion

Updated Narratives

LFMD logo

LifeMD is a diamond in the making

Fair Value: US$30.3 89.3% undervalued intrinsic discount
17 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
LFMD logo

LFMD: Telehealth Focus And Weight Management Reset Will Drive Future Margin Expansion

Fair Value: US$9.25 65.1% undervalued intrinsic discount
18 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
LFMD logo

Intensifying Regulation And Churn Will Limit Prospects While Stability Emerges

Fair Value: US$8 59.6% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet and fair value.

2 Risks
2 Rewards

LifeMD, Inc. Key Details

US$250.1m

Revenue

US$32.9m

Cost of Revenue

US$217.2m

Gross Profit

US$228.3m

Other Expenses

-US$11.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.23
86.84%
-4.45%
0%
View Full Analysis

About LFMD

Founded
1994
Employees
306
CEO
Justin Schreiber
WebsiteView website
lifemd.com

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology. It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Recent LFMD News & Updates

Recent updates

No updates